ArticleGynecologic oncology reports2025
Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report.
Katie Foug et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.